We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+9.71%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$54.9B
AUM Growth
-$1.43B
Cap. Flow
-$10.1B
Cap. Flow %
-18.32%
Top 10 Hldgs %
15.84%
Holding
4,613
New
106
Increased
2,539
Reduced
1,420
Closed
185

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Financials 5.47%
3 Healthcare 4.96%
4 Consumer Discretionary 4.64%
5 Industrials 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMBM
4051
DELISTED
Cambium Networks
CMBM
$5.77K ﹤0.01%
660
+111
+20% +$861
NCSM icon
4052
NCS Multistage Holdings
NCSM
$135M
$5.75K ﹤0.01%
137
+49
+56% +$2.14K
CIX icon
4053
Comp X International
CIX
$391M
$5.73K ﹤0.01%
393
+162
+70% +$2.37K
CHRA
4054
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$5.68K ﹤0.01%
233
+86
+59% +$1.81K
SONM icon
4055
DNA X Inc
SONM
$5.22M
$5.61K ﹤0.01%
+1
New +$4.93K
RFP
4056
DELISTED
Resolute Forest Products Inc.
RFP
$5.47K ﹤0.01%
1,303
-227
-15% -$943
YCBD icon
4057
cbdMD
YCBD
$6.39M
$5.39K ﹤0.01%
7
+6
+600% +$7.2K
CODA icon
4058
Coda Octopus Group
CODA
$116M
$5.37K ﹤0.01%
642
+413
+180% +$3.16K
CKPT
4059
DELISTED
Checkpoint Therapeutics
CKPT
$5.36K ﹤0.01%
312
+200
+179% +$3.35K
SER icon
4060
Serina Therapeutics
SER
$41.8M
$5.26K ﹤0.01%
82
+19
+30% +$1.03K
CTRC
4061
DELISTED
Centric Brands Inc. Common Stock
CTRC
$5K ﹤0.01%
2,303
+1,487
+182% +$3.72K
AXLA
4062
DELISTED
Axcella Health Inc. Common Stock
AXLA
$4.98K ﹤0.01%
50
+47
+1,567% +$5.17K
PHUN icon
4063
Phunware
PHUN
$43.2M
$4.92K ﹤0.01%
83
+79
+1,975% +$5.45K
PRMW
4064
DELISTED
Primo Water Corporation
PRMW
$4.91K ﹤0.01%
359
-384
-52% -$5.01K
ECOR icon
4065
electroCore
ECOR
$83.2M
$4.82K ﹤0.01%
202
+60
+42% +$1.53K
MUX icon
4066
McEwen Inc
MUX
$1.19B
$4.79K ﹤0.01%
377
+1
+0.3% +$14
GCVRZ
4067
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$4.69K ﹤0.01%
5,455
JILL icon
4068
J. Jill
JILL
$278M
$4.54K ﹤0.01%
803
+253
+46% +$1.99K
GWGH
4069
DELISTED
GWG Holdings, Inc
GWGH
$4.32K ﹤0.01%
440
+263
+149% +$2.59K
ASR icon
4070
Grupo Aeroportuario del Sureste
ASR
$8.28B
$4.31K ﹤0.01%
23
VALU icon
4071
Value Line
VALU
$355M
$4.25K ﹤0.01%
147
-28
-16% -$715
NTGN
4072
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$4.06K ﹤0.01%
3,439
+1,095
+47% +$1.75K
ASAP
4073
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$3.81K ﹤0.01%
592
+259
+78% +$2.87K
YGYI
4074
DELISTED
Youngevity International, Inc Common Stock
YGYI
$3.69K ﹤0.01%
1,131
+723
+177% +$3.04K
FSK icon
4075
FS KKR Capital
FSK
$3.35B
$3.5K ﹤0.01%
143

Similar funds

BNP Paribas Financial Markets's Q4 2019 Portfolio in Review

As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.

  • BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
  • BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
  • BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
  • BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
  • BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
  • BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
  • BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.